Emergent BioSolutions Authorizes $50 Million Stock Buyback Program

, MT Newswires -  9:14 AM ET 3/31/2025 default

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print

09:14 AM EDT, 03/31/2025 (MT Newswires) -- Emergent BioSolutions ( EBS ) said Monday its board has authorized the repurchase of up to $50 million of its common stock through March 27, 2026.

The new stock buyback program may be suspended or discontinued at any time, the vaccines and specialty medicines company said, adding it had around 54.3 million shares outstanding at the end of 2024.

Emergent shares were ahead 3% in Monday's premarket activity.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

© 1999-2025 Midnight Trader, Inc. All rights reserved.

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print
close
Please enter a valid e-mail address
Please enter a valid e-mail address
Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "

Your e-mail has been sent.
close

Your e-mail has been sent.